2017
DOI: 10.1002/nbm.3754
|View full text |Cite
|
Sign up to set email alerts
|

Global brain metabolic quantification with whole‐head proton MRS at 3 T

Abstract: SUMMARY NAA, Cr and Cho 1H-MRS signals are often used as surrogate markers in diffuse neurological pathologies, but spatial coverage of this methodology is limited to 1%–65% of the brain. Here we wish to demonstrate that non-localized, WH 1H-MRS, captures just the brain’s contribution to the Cho and Cr signals, ignoring all other compartments. Towards this end 27 young healthy adults (18 men, 9 women), 29.9±8.5 years old, were recruited and underwent T1-weighted MRI for tissue segmentation, non-localizing, ~3 … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
3
1

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 64 publications
0
4
0
Order By: Relevance
“… Bottom : Same from their age and gender matched controls (numbers 18, 22 and 23 in Table 2). Note (i) the small residuals (reflecting VeSPA fit’s quality), that are likely due to the limited number of metabolites in the fitting basis set; and possible lineshape differences between the measured in vivo peaks and the assumed Voight basis functions used by the VeSPA software; (ii) excellent lipid suppression performance; and (iii) while the acquisition is non-localizing, the metabolites’ spectra come from the brain only (Kirov et al, 2017). …”
Section: Figmentioning
confidence: 99%
See 1 more Smart Citation
“… Bottom : Same from their age and gender matched controls (numbers 18, 22 and 23 in Table 2). Note (i) the small residuals (reflecting VeSPA fit’s quality), that are likely due to the limited number of metabolites in the fitting basis set; and possible lineshape differences between the measured in vivo peaks and the assumed Voight basis functions used by the VeSPA software; (ii) excellent lipid suppression performance; and (iii) while the acquisition is non-localizing, the metabolites’ spectra come from the brain only (Kirov et al, 2017). …”
Section: Figmentioning
confidence: 99%
“…We address all these issues with a non-localizing 1 H-MRS sequence that acquires the whole-head signal (Gonen et al, 1998; Soher et al, 2014), and that has recently been shown to yield contributions from only the whole-brain (WB), the compartment of interest (Kirov et al, 2017). In this paper, we use the recently developed full spectral-modeling for WB 1 H-MRS (Soher et al, 2014), in order to test the hypothesis that despite lack of atrophy, brains of patients with localization-related epilepsy incur neuronal dysfunction well beyond the ictal zone, reflected by a decrease in their global NAA concentration.…”
Section: Introductionmentioning
confidence: 99%
“…By comparison, studies of brain metabolite concentrations in PHIV using proton magnetic resonance spectroscopy (MRS) were less common (Van den Hof et al, 2019). MRS allows for the acquisition of various metabolites, including N-acetylaspartate (NAA) as a proxy for neuronal density and viability, total choline (tCho) as an indicator of cell membrane turnover and gliosis, and total creatine (tCre) as a marker for cellular energy metabolism (Kirov et al, 2017). In general, contradictory findings have emerged from MRS studies of neurometabolites in PHIV (Keller et al, 2004;Nagarajan et al, 2012;Iqbal et al, 2016;Mbugua et al, 2016;Van Dalen et al, 2016;Robertson et al, 2018;Van den Hof et al, 2019;Graham et al, 2020).…”
Section: Introductionmentioning
confidence: 99%
“…It shows the different ratios present in the studies. Such as Vallée et al, [21] Di Costanzo, [22] Huang [23] andMatsusue[18] radiological findings reported results for rCBV, Cho/NAA, and Cho/Cr while Elias[24] and Kirov et al[25] reported on Cho/Cr and Cho/NAA. Whereas, Alexiou et al,…”
mentioning
confidence: 99%